Paul Kim, CFO and Treasurer of Fulgent Genetics, Inc., filed a statement of changes in beneficial ownership on October 28, 2026, reporting a disposition of common stock on October 26, 2026.

Key Highlights

  • Reporting person: Paul Kim, CFO and Treasurer of Fulgent Genetics, Inc. (NASDAQ:FLGT)
  • Transaction: 2,748 shares of common stock disposed of (transaction code F) on October 26, 2026
  • Price per share: $20.22
  • Purpose: Shares withheld to satisfy tax withholding obligations upon vesting of certain restricted stock units
  • RSU origin: Awards originally stemmed from the Agreement and Plan of Merger dated November 7, 2022
  • Beneficial ownership after transaction: 353,795 shares of common stock held directly

CFO Paul Kim Reports Tax-Related Share Withholding at Fulgent Genetics

According to the filing, Paul Kim, who serves as CFO and Treasurer of Fulgent Genetics, Inc. (NASDAQ:FLGT), reported a disposition of 2,748 shares of the company's common stock on October 26, 2026. The transaction was coded "F," indicating shares withheld by the issuer rather than an open-market sale. The shares were withheld at a price of $20.22 per share to cover tax withholding obligations that arose upon the vesting of restricted stock units.

The filing notes that the restricted stock units in question were assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022, by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. According to the filing, these awards were originally reported on a Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022. Fulgent Genetics is a genomic testing company that provides a broad range of genetic testing services.

Following the reported transaction, the filing discloses that Paul Kim directly and beneficially owns 353,795 shares of Fulgent Genetics common stock. No derivative securities were reported as acquired or disposed of in connection with this filing. The filing was submitted by one reporting person and was signed on October 28, 2026.

What Was Disclosed

The filing disclosed that Fulgent Genetics CFO and Treasurer Paul Kim had 2,748 shares of common stock withheld on October 26, 2026, at $20.22 per share, to satisfy tax obligations on vesting restricted stock units tied to a November 2022 merger agreement, leaving him with 353,795 directly held shares.